Vivekanand Jha's Publications

About Vivekanand Jha's Publications

Executive Director, The George Institute for Global Health, India
  • PHD

  • Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial

    BMC Infectious Diseases Date published:

  • Global availability of medications and health technologies for kidney care: A multinational study from the ISN-GKHA

    PLOS Global Public Health Date published:

  • A Roadmap for Disaster Risk Reduction and Management in Kidney Care

    Journal of the American Society of Nephrology Date published:

  • WCN25-3626 ASSESSMENT OF CAUSES OF DEATH IN A POPULATION-REPRESENTATIVE COHORT AT RISK OF CHRONIC KIDNEY DISEASE OF UNKNOWN ORIGIN, USING SmartVA TECHNOLOGY

    Kidney International Reports Date published:

  • WCN25-3639 GEORSPATIAL ANALYSIS OF CKD HOT SPOTS: INSIGHTS FROM 0.1 MILLION PARTICIPANTS SCREENING IN UDDANAM, INDIA

    Kidney International Reports Date published:

  • WCN25-3917 CKD IN HIGH-ENDEMIC REGIONS: COMMUNITY INSIGHTS FROM SELF-REPORTED, NEWLY DIAGNOSED, AND NON-CKD RESIDENTS

    Kidney International Reports Date published:

  • WCN25-4280 INCIDENCE AND RATE OF CHANGE IN ESTIMATED GFR: A 5-YEAR PROSPECTIVE POPULATION-REPRESENTATIVE SURVEY IN UDDANAM, INDIA

    Kidney International Reports Date published:

  • WCN25-4408 Clinical Outcomes of FSGS with Nephrotic Syndrome at 1-Year: Findings from the ITANGIBLE Registry

    Kidney International Reports Date published:

  • WCN25-4441 Decoding Glomerulonephritis: Baseline Profiles and Insights from the I-TANGIBLE Registry

    Kidney International Reports Date published:

  • WCN25-4459 Baseline parameters of patients with FSGS and MN enrolled in the ITANGIBLE registry

    Kidney International Reports Date published:

  • WCN25-4466 Baseline parameters of IgA Nephropathy Using the Oxford MEST Score: Insights from the I-TANGIBLE Registry

    Kidney International Reports Date published:

  • WCN25-2664 Low-dose versus Standard-dose cyclical Cyclophosphamide and Steroids in the treatment of Primary Membranous Nephropathy- a randomized controlled trial

    Kidney International Reports Date published:

  • WCN25-3793 UNDERSTANDING THE GLOBAL BURDEN OF RARE KIDNEY DISEASE: A SCOPING REVIEW

    Kidney International Reports Date published:

  • WCN25-2470 Long-term Results from the ORIGIN Phase 2b Study of Atacicept for the Treatment of IgAN

    Kidney International Reports Date published:

  • WCN25-825 BARRIERS PATIENTS FACE IN INCREASING HEMODIALYSIS FREQUENCY - A NATIONWIDE CROSS-SECTIONAL STUDY IN INDIA, 2023

    Kidney International Reports Date published:

  • WCN25-4102 N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE (NT-proBNP) AND PROGRESSION OF CHRONIC KIDNEY DISEASE IN INDIAN CHRONIC KIDNEY DISEASE COHORT

    Kidney International Reports Date published: